Zostavax (Zoster Vaccine, Live)
Detailed View: Safety Labeling Changes Approved By FDA Center for Biologics Evaluation and Research (CBER)
February 2016
ADVERSE REACTIONS
Postmarketing
Eye Disorders: necrotizing retinitis (patients on...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts